|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
SE9602442D0
(sv)
*
|
1996-06-20 |
1996-06-20 |
Astra Ab |
Administration of pharmaceuticals
|
|
US6331181B1
(en)
|
1998-12-08 |
2001-12-18 |
Intuitive Surgical, Inc. |
Surgical robotic tools, data architecture, and use
|
|
ES2237809T3
(es)
*
|
1997-02-28 |
2005-08-01 |
Kaneka Corporation |
Medicina curativa para la enfermedad causada por infeccion de helicobacter.
|
|
WO1999004816A1
(en)
*
|
1997-07-25 |
1999-02-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Proton pump inhibitor in therapeutic combination with antibacterial substances
|
|
IN186245B
(cg-RX-API-DMAC7.html)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
|
SE9704869D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
|
SK10272000A3
(sk)
*
|
1998-01-16 |
2001-01-18 |
Takeda Chemical Industries, Ltd. |
Prostriedok s trvalým uvoľňovaním, spôsob jeho výroby a jeho použitia
|
|
US5981499A
(en)
*
|
1998-02-20 |
1999-11-09 |
Atlantic Biomed Corporation |
Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
|
|
CA2362930C
(en)
*
|
1999-02-26 |
2010-10-05 |
Nitromed, Inc. |
Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
|
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
US6248718B1
(en)
|
1999-08-18 |
2001-06-19 |
Atlantic Biomed Corporation |
Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
|
WO2002026210A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Proton pump inhibitor formulation
|
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
|
ATE306940T1
(de)
*
|
2000-12-04 |
2005-11-15 |
New Pharma Res Sweden Ab |
Zusammensetzung gegen coccidiose
|
|
ATE529097T1
(de)
*
|
2000-12-07 |
2011-11-15 |
Nycomed Gmbh |
Pharmazeutische zubereitung in form einer paste mit einem säurelabilen wirkstoff
|
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
|
SE0101379D0
(sv)
*
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
DE10145457A1
(de)
*
|
2001-09-14 |
2003-04-03 |
Basf Ag |
Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
|
|
US20050048077A1
(en)
*
|
2002-02-21 |
2005-03-03 |
George Sachs |
Compositions, test kits and methods for detecting helicobacter pylori
|
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
|
EP1534278A4
(en)
|
2002-08-01 |
2006-09-06 |
Nitromed Inc |
NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
|
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
|
AU2003284942A1
(en)
*
|
2002-10-30 |
2004-06-07 |
Pharmacia Corporation |
Oral extended release tablets and methods of making and using the same
|
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
|
WO2004087175A1
(en)
*
|
2003-04-04 |
2004-10-14 |
Pharmacia Corporation |
Oral extended release compressed tablets of multiparticulates
|
|
BR0300882A
(pt)
*
|
2003-04-09 |
2005-05-10 |
Cmax Otimizacao De Resultados |
Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
|
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
WO2005009365A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
|
US8425936B2
(en)
|
2003-07-21 |
2013-04-23 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
|
US8313775B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
|
EP1653925A1
(en)
|
2003-08-11 |
2006-05-10 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
|
CA2535780A1
(en)
*
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
|
US20050232992A1
(en)
*
|
2003-09-03 |
2005-10-20 |
Agi Therapeutics Limited |
Proton pump inhibitor formulations, and methods of preparing and using such formulations
|
|
EP1663169A4
(en)
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
ANTIBIOTICS, ITS USE AND FORMULATION
|
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
|
KR100581967B1
(ko)
*
|
2003-12-18 |
2006-05-22 |
한국유나이티드제약 주식회사 |
소화성 궤양 치료를 위한 프로톤펌프 저해제와클래리스로마이신을 함유하는 이중 펠렛 제제 및 그의제조방법
|
|
US20050181052A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Patel Satishkumar A. |
Lansoprazole microtablets
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
WO2006014427A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
|
WO2006037766A1
(en)
*
|
2004-10-05 |
2006-04-13 |
Altana Pharma Ag |
Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
|
|
US7981908B2
(en)
*
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
|
US7803817B2
(en)
*
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
|
WO2007078874A2
(en)
*
|
2005-12-30 |
2007-07-12 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
|
EP1803450A1
(en)
|
2006-01-03 |
2007-07-04 |
Ferrer Internacional, S.A. |
Pharmaceutical compositions for the eradication of helicobacter pylori
|
|
CN1857220B
(zh)
*
|
2006-04-04 |
2010-10-06 |
济南康泉医药科技有限公司 |
一种抗结核病药物缓释剂
|
|
DK2007362T3
(en)
|
2006-04-04 |
2018-11-26 |
Kg Acquisition Llc |
ORAL DOSAGE FORMS, INCLUDING AN ANTITHROMOBOCYTY AGENT AND AN ACID INHIBITOR
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
AU2007278986B2
(en)
*
|
2006-07-25 |
2010-09-16 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
|
|
EP2152263A1
(en)
*
|
2007-06-07 |
2010-02-17 |
Dynogen Pharmaceuticals, Inc. |
Compositions useful for treating gastroesophageal reflux disease
|
|
JP2012502015A
(ja)
|
2008-09-09 |
2012-01-26 |
アストラゼネカ・アクチエボラーグ |
必要がある患者に医薬組成物を送達するための方法
|
|
WO2010151216A1
(en)
|
2009-06-25 |
2010-12-29 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
|
US20130096123A1
(en)
*
|
2010-04-14 |
2013-04-18 |
Eupharma Pty Ltd |
Radiation sensitiser compositions
|
|
EA028049B1
(ru)
|
2011-12-28 |
2017-10-31 |
Поузен Инк. |
Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
|
|
CN110366415A
(zh)
*
|
2017-10-15 |
2019-10-22 |
消化系统疾病中心 |
用于治疗、减轻和预防幽门螺杆菌感染的组合物和方法
|
|
WO2025067633A1
(en)
|
2023-09-26 |
2025-04-03 |
Amyra Biotech Ag |
Pharmaceutical compositions comprising aminopeptidase and dipeptidylpeptidase polypeptides and uses thereof
|
|
WO2025067635A1
(en)
|
2023-09-26 |
2025-04-03 |
Amyra Biotech Ag |
Pharmaceutical compositions comprising exopeptidases and uses thereof
|